Caption Management »

Summit Therapeutics shares owned by Caption Management

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Caption Management from 13F filings

Historical chart of Caption Management investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Caption Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Caption Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.4M 359k 20.66
2025-06-30 $23M 1.1M 21.28
2025-03-31 $386k 20k 19.29
2024-06-30 $9.5M 1.2M 7.80

More positions owned by Caption Management

Carvana Cl A Call Option (CVNA)
Coreweave Com Cl A Call Option (CRWV)
Intuit Call Option (INTU)
Tesla Motors Put Option (TSLA)
United Therapeutics Corporation Call Option (UTHR)
Amazon Put Option (AMZN)
Reddit Cl A Call Option (RDDT)
Applovin Corp Com Cl A Call Option (APP)
NVIDIA Corporation Put Option (NVDA)
Echostar Corp Cl A Call Option (SATS)
Chevron Corporation Call Option (CVX)
Sable Offshore Corp Com Shs Call Option (SOC)
Iren Ordinary Shares Call Option (IREN)
Core Scientific Call Option (CORZ)
Coinbase Global Com Cl A Call Option (COIN)

View all positions for Caption Management

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
FMR
BlackRock
State Street Corporation
Geode Capital Management
Susquehanna International
Pictet Asset Management Holding SA
Citadel Advisors
UBS Group
Apeiron Capital
Nomura Holdings
Standard Life Aberdeen
Squarepoint Ops
Sofinnova Ventures

View all funds holding Summit Therapeutics